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Silicon supplementation has been shown to play an important role in skeleton development, however, the 5 
potential role that silicon plays in mediating bone formation, and an understanding of where it might 
localise in the resulting bone tissue remain elusive.  An improved understanding of these processes could 
have important implications for treating pathological mineralisation. A key aspect of defining the role of 
silicon in bone is to characterise its distribution and coordination environment, however, there is currently 
almost no information available on either.  We have combined a sample-preparation method that 10 
simultaneously preserved mineral, ions, and the extracellular matrix (ECM) with secondary ion mass 
spectroscopy (SIMS) and electron energy-loss spectroscopy (EELS) to examine the distribution and 
coordination environment of silicon in murine osteoblasts (OBs) in an in vitro model of bone formation. 
SIMS analysis showed a high level of surface contamination from polydimethysiloxane (PDMS) resulting 
from sample preparation. When the PDMS was removed, silicon compounds could not be detected within 15 
the nodules either by SIMS or by energy dispersive x-ray spectroscopy (EDX) analysis. In comparison, 
electron energy-loss spectroscopy (EELS) provided a powerful and potentially widely applicable means 
to define the coordination environment and localisation of silicon mineralising tissues.  We show that 
trace levels of silicon were only detectable from the mineral deposits of the mineralised nodules.  Taken 
together our results suggest that silicon plays a biological role in bone formation, however, the 20 
mechanism by which silicon exerts its physicochemical effects remains uncertain.  Our analytical results 
open the door for compelling new sets of EELS experiments that can provide detailed and specific 
information about the role that silicates play in bone formation and disease. 
1. Introduction  
Several reports have indicated that silicon plays an important role 25 
in bone formation by increasing matrix synthesis and the 
differentiation of osteoblast cells1-6. Silicon has also been found to 
be essential for skeleton development1-4, and chickens fed with a 
Si-deficient diet have significantly smaller, shorter and thinner leg 
bones3 compared to chickens treated with a silicon supplemented 30 
diet. Si-deficiency also causes abnormalities in the skulls of rats; 
they are distorted and shorter than in normal healthy rats2. Addition 
of silicon compounds to osteoblast cell cultures has also been 
reported to have a biochemical effect on osteoblast function and 
appears to play a role in mineralization5, 6. Silicon has been shown 35 
to be an essential element in the synthesis and formation of 
collagen2-5 and in vitro studies demonstrated positive effects of 
silicon on osteoblast proliferation and activity5. The silicon 
containing compound, zeolite A (ZA), which is composed of 
(SiO4)4- and (AlO4)5-, promoted DNA synthesis, alkaline 40 
phosphatase (ALP) activity, osteocalcin production and a post-
translational process of transformation growth factor  (TGF-β) in 
osteoblasts (OB)5. It is also widely accepted that incorporation of 
0.8wt% silicon into calcium phosphate increases the bioactivity of 
implants6-8.   Silicon susbstituted hydroxayaptite (Si-HA) implants 45 
were able to promote bone remodelling around the implant, as 
evidenced by the collagen fibrils being more aligned and organized 
around the Si-HA implant 6 weeks after implantation8. Si-HA also 
increased the alkaline phosphatase (ALP) activity and total protein 
production by human OBs in culture compared to pure HA6. In 50 
short, silicon appears to affect osteoblast function and bone 
formation, however, the localisation and coordination environment 
of silicon within bone tissue (i.e. whether it partitions to the 
collagen fibrils, mineral or cells) remain elusive. 
 55 
Despite the interest in the role of silicon in bone formation and 
mineralisation, there is almost no information available about the 
distribution of silicon in bone.  Furthermore, no studies are 
available which have characterised the coordination environment 
of the silicon due to the complexity of performing this analysis.  In 60 
a series of experiments using electron probe microanalysis, 
Carlisle reported detection of silicon (up to a maximum level of 0.5 
wt %) within the unmineralized osteoid regions, that is, active 
calcification sites, of normal tibiae from young mice and rats4. A 
later report by Landis et al., mapped the distribution of silicon and 65 
calcium in the growing long bones which had been prepared using 
anhydrous organic solvents from normal embryonic chicks and 
young rats by SIMS1.  This work supported the earlier work by 
Carlisle and showed that silicon localised to the putative 
uncalcified osteoid regions of tibiae (1). However neither study 70 
thoroughly examined the preparation protocol relative to silicon or 
provided information about the coordination environment of the 
silicon; the room temperature preparation methods used may lead 
to movement, redistribution or loss of silicon during tissue 
processing. In addition, it is not clear from these earlier studies 75 
whether any silicon contamination had been removed.  Despite the 
remarkable developments that have occurred in the field of 
nanometer-scale analysis over the past decade, no nanoscale 
analytical studies have followed up on these early studies. 
 80 
One of the major challenges with mapping the distribution of 
silicon in tissues arises due to the low levels present, typically only 
100 ppm is present in bone and ligament2. Very few techniques are 
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therefore available to detect the low concentrations of silicon 
present.  Preservation of the native structure and chemistry of the 
tissue is also challenging and artefacts introduced during TEM 
sample preparation can be extremely subtle.  It is also challenging 
to remove silicon-containing contaminants from the surface of the 5 
sample which can be problematic since these contaminants 
interfere with subsequent STEM-EELS analysis of both silicon and 
also phosphorus. The aim of this study is to map the distribution of 
silicon in mineralised bone tissue nodules formed from OBs. The 
combination of time of flight (TOF)-SIMS with spatially resolved 10 
nanoanalytical electron microscopy techniques could be 
advantageous for identifying the source of contamination. OBs are 
bone forming cells in vivo and form mineralised nodules in vitro 
when cultured under specific conditions. Our previous studies have 
demonstrated that they act a good model to study bone 15 
mineralisation9, 10.  Through this study, we aim to develop a 
protocol which allows for simultaneous preservation and detection 
of the chemistry and structure of ions, minerals and cell 
ultrastructure within the bone mineralised nodules, to accurately 
map the distribution of elements and their coordination 20 
environment during the early stages of bone formation.  
 
2. Materials and Methods 
2.1 Silicon-substituted hydroxyapatite (Si-HA) with 0.8 wt. % 
silicate ion substitution was produced the aqueous precipitation 25 
reaction between calcium hydroxide [Ca(OH)2] and 
orthophosphoric acid [H3(PO)4] with silicon acetate 
[Si(CH3COO)4] as the silicon source11. The resulting compound 
was mixed with a low molecular weight polymer to form a slip, 
which is then agitated to create a foam. Once dry, the material was 30 
sintered at 1250 °C to burn out the polymer and densify the 
ceramic. The resulting material has interconnected total porosity of 
80 % ± 2.5%. Details of the characterization of the porous Si-HA 
granules (X-ray diffraction, level of porosity) are given 
elsewhere12. 35 
 
2.2 Primary cell extraction  
Mouse calvarial osteoblasts (OBs) were isolated, expanded and 
cultured to form mineralised nodules according to the protocols 
described previously9. Briefly, mouse OBs were obtained from 40 
calvarias of neonatal mice (2 days old). Calvarias were removed, 
washed in phosphate buffered saline, cut and then digested 5 times 
in a 10% v/v solution of 0.05% v/v trypsin/EDTA (Invitrogen) in 
Hank’s balanced salt solution containing 1.0 mg/mL collagenase 
at 37°C, 20 minutes for each of the first 4 digestions and 2 hours 45 
for the last digestion. Supernatant from the last 3 digestions was 
pooled and centrifuged at 200g for 5 minutes to collect cell pellets. 
The cell pellet was re-suspended in αMEM supplemented with 
15% v/v FBS and 1X P/S and plated on standard tissue culture 
plastic. 50 
 
2.3 Mineralised nodule formation 
To induce mineralized nodule formation, cells were plated on 
sapphire discs (Leica Microsystems) at 30,000 cells/cm2 in αMEM 
supplemented with 15% (v/v) FBS, 1X P/S, 50 µg/mL ascorbic 55 
acid, and 10 mM β-glycerophosphate (both from Sigma) according 
to a widely use protocol for in vitro differentiation of mineralising 
cells (13-21). Dexamethasone was added to all cultures at a 
concentration of 1 µM beginning at day 14 and cultivation was 
continued until day 28. The culture medium was changed every 60 
two days.  
 
2.4 Sample preparation for TEM  
Mineralised nodules (on sapphire disc) were placed on specimen 
carriers with 200 µm deep cavities, mounted in a 20% (w/v) 65 
solution of bovine serum albumin (Sigma) in αMEM and frozen 
using with a Leica EM PACT 2 high pressure freezer. Freeze-
substitution was performed in a Leica EM AFS2 freeze substitution 
device using an anhydrous solution of acetone containing a 3% 
(v/v) glutaldehyde, 1% (w/v) osmium tetroxide and 0.5% (w/v) 70 
uranyl acetate at -90 ˚C for 8 hours. Samples were then gradually 
warmed to 0 ˚C at 5 ˚C/hour, washed twice in acetone, brought to 
room temperature and infiltrated with Quetol-based resin (12.6g 
Quetol, 15.5g Nonenyl succinic anhydride (NSA), 6.5g Methyl 
nadic anhydride (MNA) and 0.6g Benzyl dimethylamine 75 
(BDMA)). The specimens were infiltrated in the Quetol-based 
resin at a ratio of 1:1, 3:1 (resin: acetonitrile) and pure resin for 2 
hours, overnight and 4 days, respectively. Pure resin was changed 
every 24 hours. Embedded samples were polymerized at 60˚C for 
24 hours. 70 nm thick sections were cut onto a water bath via 80 
ultramicrotomy using a 35o diamond knife.  The sections were 
collected immediately on bare 300 mesh copper TEM grids and 
dried immediately on filter paper. Particular care was given to 
preserve the chemistry of the mineral and also to reduce any 
contamination. The EELS study was carried out in 5 different 85 
regions within the OB nodule. A full discussion of the sample 
preparation protocols used is provided in ref.10. 
 
2.5 Scanning transmission electron microscopy (STEM) 
High angle annular dark field STEM (HAADF-STEM) and 90 
STEM-EELS were performed on a Titan 80/300 STEM/TEM 
operated at 300kV. STEM images were recorded using a HAADF 
detector with inner and outer semi-angle of 40 and 196 mrad, 
respectively. EELS was carried out in STEM mode under the same 
operating conditions. The convergence and collection semi-angles 95 
into the spectrometer were set to 6.8 and 8.90 mrad, respectively. 
The energy resolution was 1 eV and the dispersion was set to 0.1 
eV/pixel to collect the characteristic Si L2,3- edge. The EEL spectra 
were acquired from an area that had a relative thickness (t/λ) of 
less than 0.4. A more detailed description of the STEM-EELS 100 
protocols can be found in ref. 10 . 
 
2.6 STEM-EDX 
The EDX spectra were collected using a Tecnai F20XT 
microscope operating at 200kV. In STEM mode the sample was 105 
tilted to face the EDAX SiLi EDX detector to optimise the signal. 
 
2.7 Time of flight secondary ion mass spectrometry (TOF-
SIMS) 
ToF-SIMS was carried out using an Ion Tof ToF-SIMS V 110 
instrument. The instrument is fitted with a 25 keV Bi+ analytical 
ion beam and Cs+, O2+ and C60+ sputter ion beams. The SIMS 
instrument was used to obtain both ion images and mass spectra 
from the sample. In both the imaging and mass spectra modes 
positive secondary ions were collected. The electron flood gun 115 
(20eV) was also applied to avoid charging of the sample during the 




2.8 Ion- imaging 
The sputter cleaning was performed using the 10keV C60+ ion 
beam. The ion beam current was 300pA, and the area cleaned was 5 
500×500 µm2. The Si+ ion signal was monitored during the sputter 
cleaning and after 100 seconds of sputtering was found to be no 
longer decreasing.  
After ion beam cleaning, the sample surface was then ion imaged 
using a Bi3+ ion beam in burst alignment mode (BAM) for high 10 
lateral resolution. The ion beam current was 0.003pA and the area 
analysed was 200×200 µm2 with 512×512 pixels. A total of 20 
scans were carried out, and the total ion beam dose was kept well 
below the static SIMS limit. 
2.9 Mass Spectra 15 
Once the ion images had been taken, mass spectra were taken in 
specific regions of the mineralised nodules. The mass spectra were 
obtained using the Bi+ ion beam in high current bunched mode 
(HCBM) with a beam current of 1pA at 100 µs cycle time for  high 
mass resolution and good ion yields. The analytical area was 50×50 20 
µm2 with 128×128 pixels. A total of 50 scans were taken and again 
the ion beam dose was below the static SIMS limit. 
 
2.9 Scanning electron microscopy (SEM) was performed on a 
JEOL JSM 5610 LV, operated at 20 kV. The SEM images were 25 




3.1 STEM-EELS 30 
At day 28, the OBs were embedded within mineralized nodules 
containing a collagenous matrix and mineralized collagen (Figure 
1).  Mitochondria in the OBs contained dense mineral aggregates 
with a disordered morphology with a diameter of 47.6±16.8 nm 
(n=50).  The composition and morphology of the granules was 35 
characterized by STEM-EELS (Figure 2). EELS spectrum 
acquired from these mitochondrial granules show a characteristic 
P L2,3- and Ca L2,3- edges at 132 and 346 eV, respectively. Further 
characterization of these mitochondrial granules, including the 
high resolution TEM images, are described in our previous 40 
publication10. The distribution and composition of silicon-
containing material were studied in several regions of the OB 
nodules. Si L2,3- edges were evident in representative spectra taken 
from several areas (Figure 2), including the mitochondria (MG), 
cytoplasm (Cyt), and small and large aggregates of mineral (M1 45 
and M2). The Si L2,3 edge had two peaks split by 8 eV (labelled 
with A and B), and a broad peak (C) which is more intense than 
the first two peaks. These EEL spectra had a near edge structure 
which corresponds to tetrahedral SiO44- units22, 23. 
  50 
3.2 ToF-SIMS 
In order to confirm that the silicon detected was not solely due to 
contamination, the embedded OB nodules were subsequently 
analysed using ToF-SIMS. To calibrate the instrument, a sample 
of 0.8 wt% silicon-substituted hydroxyapatite (Si-HA) was used as 55 
a standard to identify the Si and Ca peaks. Figure 3 shows the mass 
spectra obtained with the most relevant Si and Ca peaks indicated. 
On the standard Si-HA sample the SiO+ peak is hidden by the very 
strong 44Ca+ peak, and contamination also masks the SiO2+ peak. 
However, the Si+, SiCaO+, and SiO4+ peaks were resolved, with a 60 
detection limit for Si+ of approximately 40ppm. This analysis 
confirmed that silicon is present as a silicate in synthetic Si-HA. 
 
Figure 1: HAADF-STEM image of a cross section through 
osteoblast (OB) nodules showing the OBs surrounded by a 
collagenous matrix (C) and mineralized collagen (M). Mitochondria 
(Mt) containing calcium phosphate are present within the OBs 
(arrows). 
 
Figure 2: EEL spectra acquired from several regions in OB nodule; 
mitochondria granule (MG), cytoplasm (Cyt), extracellular matrix 
(ECM), mineral aggregate (M1) and mineral deposit (M2). The 
backgrounds were subtracted using a power law model,and aligned and 
shifted along the y-axis. Each spectrum was labelled with the same colour 
as the marked area they were obtained from. Si L2,3 edge at 99 eV present 
in all spectra, except the one from ECM. The spectra obtained from MG, 
M1 and M2 show P L2,3 and Ca L2,3  edges at 132 and 346 eV, respectively. 
The C K edge is present in all spectra at 280 eV. 
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Initial ion images obtained from the surface of embedded 
mineralised nodules, which had been cut by ultramicrotomy for 
STEM-EELS analysis, indicated the presences of surface 
contamination as the surface was entirely covered with Si 5 
containing compounds (Figure 4b). Ca+ ion images highlighted the 
mineralised regions in OB nodules (Figure 4a). The mass 
spectrumtaken from the surface clearly showed the characteristic 
peaks of PDMS (main peaks at SiCH3+, SiC2H7+, SiC3H+, 
Si2C5H15O+, Si3C5H15O3+ and Si3C7H21O2+)24 (Supplementary 10 
Figure 1). To remove the contamination, the sample was sputter 
cleaned with a C60+ sputter gun. During the sputter cleaning C+, 
Na+, Si+, K+ and Ca+ secondary ions were monitored. The depth 
profile shows a decrease of Si+ intensity as the organic contaminant 
was removed, while C+, Na+, K+ and Ca+ increased in intensity. 15 
The surface was sputter cleaned until all ion intensities became 
constant (Figure 4c). 
 
Ion images taken after the C60+ sputtering clearly show the extent 
of the surface contamination. A large region of the surface was 20 
mapped to show both the un-cleaned and sputter cleaned region 
(Figure 5a, b). Figure 5c, d and e show the Mg+, Si+ and Ca+ ion 
maps, respectively. The distribution of Mg+ follows closely the 
distribution of Ca+ which are the main constituents of the 
extracellular mineral phase of bone (1).  Mass spectra were taken in 25 
both the un-cleaned and cleaned regions (Supplementary 
information Figure 1). The mass spectrum on the un-cleaned part 
of the surface identified PDMS as the contaminating organic. After 
the C60+ sputter clean, most PDMS peaks are no longer visible. 
Figure 5(b) shows that the organic contaminant clearly suppresses 30 
the Ca+ ion signal, but once removed, the structure of the OB 
nodule surface can be seen. 
 
A smaller area in the cleaned region was then ion mapped in order 
to investigate the silicon distribution. Figure 5e shows ion maps of 35 
Ca+ which represent calcified regions in the mineralised nodules. 
The silicon ion map (Figure 5d) shows the localisation of silicon 
compounds only in areas that were devoid of any calcium, but not 
throughout the entire nodule. Backscattered SEM images obtained 
in the same region as the SIMS ion maps showed cracks in the 40 
mineralised regions (Figure 5g and h). The cracks observed in 
these images correlate to the region rich in silicon in Figure 5d. 
 
3.3 Chemical analysis of the non-contaminated samples 
Since,the TOF SIM result suggested that PDMS contamination 45 
 
Figure 3: Mass spectra obtained from the Si-HA standard.  
 
Figure 5: Secondary ion images (a) and (b) show respectively the Si and 
Ca distributions in the OB nodules from the unclean and cleaned regions. 
The ion images on the sputter cleaned region show the (c) Mg (d) Si and 
(e) Ca localization in the OB nodule. A false coloured overlay of these 
three ion signals is shown in (f). A back scattered image showing the 
same region as the ion images is shown in (g). The higher magnification 
back scattered image in (h) of the marked area in (g) shows a crack where 
silicon localises in mineralised ECM. 
 
Figure 4: Secondary Ca+ (a) and Si+ (b) images of the OB nodule 
(500x500 µm2) using Bi3+ ion beam. c) Depth profiles showing the 
intensity of C, Na, Si, K, and Ca, ions monitored during surface 
sputter cleaning using C60+ ions. 
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was mainly on the surface of the samples, STEM- EELS and 
STEM-EDX experiments were conducted on new sample sections 
(in regions where cracks were absent) which were handled with 
extra care so as not to generate silicon contamination. In order to 
remove the surface silicon contamination, a few micrometers of the 5 
surface contaminated block was cut away by sectioning with a 
diamond knife in the ultramicrotome, before collecting sections for 
analysis. Sections were stored on a filter paper, away from plastic 
or glass containers which may act as a source of PDMS 
contamination. EDX analysis did not detect silicon compounds in 10 
either the small or large mineral aggregates (Figure 6). EDX 
spectra instead detected the presence of calcium and a small 
amount of magnesium (Figure 6d). The collagenous matrix and 
mineral deposits in the OB nodules were analysed using STEM-
EELS to map the silicon distribution again (Figure 7). Silicon was 15 
not detected in collagenous matrix (Figure 7a); however, EEL 
spectra taken from a mineral deposit (Figure 7b) showed a very 
low intensity signal at the position of Si L2,3 -edge (99 eV).   
  
4. Discussion  20 
The main obstacle in mapping the distribution of silicon within 
biological samples is in first eliminating any silicon-containing 
contamination. The silicon signal in the EEL spectra generated 
from contamination also makes accurate detection and quantitative 
analysis of the P L2,3 edge difficult as the Si L2,3 edge overlaps with 25 
the pre-edge P L2,3 background signal. Here, we demonstrated that 
complementary analysis using STEM-EELS and SIMS enabled 
analyses of the distribution, coordination environment of silicon in 
OB nodules and also the detection of surface contamination. The 
study conclusively showed that the surface of the sample was 30 
contaminated with PDMS which can be removed by ensuring that 
the sample does not come into contact with the plastic TEM grid 
boxes or petri dishes at any point during sample preparation. When 
the silicon contaminants were fully removed, silicon was absent 
from the majority of the nodules, including the OB cytoplasm and 35 
collagenous matrix. PDMS contamination may be introduced from 
exposure to the plastic containers, such as boxes, moulds and 
bags24, and even the laboratory atmosphere25. This implies that 
samples can be contaminated during both preparation and post 
processing. However, our SIMS results showed that PDMS 40 
contamination was not in the resin that infiltrated into the sample, 
but it was only on the surface. After sputter cleaning with a C60+ 
ion beam, the OB nodule structure could be clearlyion mapped, 
however, some Si+ ions were observed in a crack on the sample 
surface. 45 
 
EEL spectroscopy indicated a trace level of Si-species present 
within the aggregates of calcium phosphate crystals located on the 
collagen and in the peripheral region of mineralised matrix, 
possibly the newly mineralised regions of the OB nodules. In the 50 
SIMS maps the distribution of Mg+ follows closely the distribution 
of Ca+ which are the main constituents of the extracellular mineral 
phase of bone1.  The magnesium may substitute for calcium in the 
hydroxyapatite lattice, which explains its presence1. However, the 
presence of silicon in mineral aggregates was not verified by EDX 55 
analysis. Increased detectability of silicon by EELS aligns with 
previous reports which have shown increased sensitivity of EELS 
of silicon compared to EDX for analysis of L2,3 shell excitations in 
the EEL spectrum and the Kα emission line in the X-ray 
spectrum26. To our knowledge this is the first time that spatially 60 
resolved EDX and EELS has been used to characterise the 
distribution of silicon in HPF/FS prepared mineralising tissues.  
 
Previous reports have suggested that silicon localises in active 
growth areas of young vertebrate bone1, 4. Silicon has also been 65 
found to co-localise with Ca and O in CaCO3 in the exocuticle of 
Ligiaitalica Fabricius cyanobacteria27. The fact that we only 
detected low levels silicon within the mineralised nodules, even 
using state-of-the-art analytical detectors and HPF/FS preparation 
techniques which will preserve the distribution of ions within the 70 
 
Figure 6: a) STEM HAADF image of a small mineral aggregate 
(arrow) b) (point) EDX spectrum acquired from the small aggregate in 
(a) (3s acquisition), the spectrum shows PKα and CaKα peaks. c) Bright 
field TEM image showing a larger aggregate and d) EDX spectrum 
taken from mineralised region in (c) with the beam concentrated on the 
aggregate (100s acquisition), the spectrum shows MgKα and CaKα 
peaks. 
 
Figure 7: HAADF STEM image taken from partially mineralised 
collageneous matrix and EELS spectra acquired in those regions (marked 
areas). EELS spectra were background subtracted using a power law 
model, aligned and shifted along the y axis. a) The mineral aggregates on 
the collageneous matrix (arrow indicating collagen fibrils) showing a line 
scan across the mineral aggregate where EELS spectrum were acquired. b) 
Spectra taken from the collagen and mineral were summed separately, 
marked as mineral (red) and ECM (blue), respectively. The sum spectrum 
taken from the ECM shows the C K edge at 280eV, while the sum spectrum 
from mineral (red) show P L2,3(132eV), C K(280 eV), CaL2,3(346 eV) edges 
and a very low intensity peak at the position of the SiL2,3 edge (99 eV). 
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nodules, brings into question whether the silicon detected in 
previous reports1,4 arose partially due to contamination or 
movement and redistribution of ions during tissue processing. 
Alternatively, the silicon may only sequester in the osteoid tissue 
at the growth plate and at earlier stages of bone formation, or the 5 
silicon present in the un-mineralised collagen was below the 
detection limit of the instruments used in this work. Our study 
correlates with other reports which show that primary osteoblasts 
can form a mineralised matrix without additional silicon-
species16,19,28. An absence of silicon has been shown to lead to an 10 
abnormality of skeleton development in rats and chickens2,3, 
however to date, no one has reported on the distribution and 
composition of Si in OB cultures. Studies have only reported on 
the positive effects of supplemented silicon on osteoblast activity, 
collagen arrangement and mineralisation5-8.  In order to rule out 15 
whether silicon would affect mineralisation or alter the 
ultrastructure of mineralised osteoblasts nodules, further studies 
need to be carried out which compare the ultrastructure of 
mineralised osteoblast nodules cultured with, and without, 
supplemented silicon. Analysis using the new generation of 20 
quantum GIF detectors may also make it possible to improve on 
the detection of silicon within tissues. 
 
Conclusions  
STEM-EELS taken from mineral deposits surrounding the OB 25 
nodules showed a very low intensity signal at the position of Si L2,3 
edge (99 eV).   In contrast, silicon was not detected by EELS in the 
collagen matrix.  We were not able to detect the presence of silicon 
convincingly within the mineralised nodules after 28 days culture 
using EDX or TOF-SIMS, which may raise questions about 30 
whether the silicon detected in bone in previous reports1, 4 arose 
partially due to contamination or redistribution and movement of 
ions within the tissue.  We suggest that a combination of analytical 
nanospectroscopy techniques of FS/HPF prepared samples can be 
applied to further elucidate whether silicon is present in bone in the 35 
early stages of collagen mineralisation or in diseased tissues.  
Moreover, these methods can be used to characterise the 
coordination environment of the silicon in bone which will provide 
new insights into the role that silicon plays in mineralisation 
processes. This correlative analytical approach could also be 40 
applied to characterise chemical speciation of ions such as silicon 
from bioactive ceramics and glasses to elucidate the underlying 
mechanisms controlling their bioactivity.  
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